These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33069259)

  • 1. Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.
    Chen Q; Wang S; Lang JH
    J Ovarian Res; 2020 Oct; 13(1):123. PubMed ID: 33069259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients.
    Liu Z; Jing C; Hooblal YM; Yang H; Chen Z; Kong F
    Front Oncol; 2024; 14():1370272. PubMed ID: 38577328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.
    Li Y; Xiu L; Ma M; Seery S; Lou X; Li K; Wu Y; Liang S; Wu Y; Cui W
    Front Oncol; 2022; 12():940601. PubMed ID: 36439411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.
    Cheng H; Xu JH; Kang XH; Wu CC; Tang XN; Chen ML; Lian ZS; Li N; Xu XL
    J Ovarian Res; 2023 Apr; 16(1):75. PubMed ID: 37059991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program.
    Gao J; Wang S; Li F; Xu H; Li X; Yan L; Zhu L
    Adv Ther; 2022 Jan; 39(1):257-285. PubMed ID: 34716558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma.
    Liu X; Lu H; Zhou Y; Long X; Li Q; Zhuang G; Yin X; Di W
    Cancer Med; 2023 May; 12(10):11385-11395. PubMed ID: 36971044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study.
    Liu T; Gao Y; Li S; Xu S
    J Ovarian Res; 2024 Jun; 17(1):119. PubMed ID: 38824600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
    Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
    J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
    Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
    Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
    Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
    BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
    BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms for primary mucinous ovarian cancer: A SEER population-based study.
    Qi X; Xu L; Wang J; Yu J; Wang Y
    J Gynecol Obstet Hum Reprod; 2022 Sep; 51(7):102424. PubMed ID: 35697250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.
    Xu D; He Y; Liao C; Tan J
    World J Surg Oncol; 2024 Jun; 22(1):151. PubMed ID: 38849854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
    Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
    J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients.
    Qi W; Ren Y; Wang H; Wan Y; Wang D; Yao J; Pan H
    Sci Rep; 2023 Dec; 13(1):23018. PubMed ID: 38155261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and validation of a nomogram for predicting cancer-specific survival in middle-aged patients with advanced hepatocellular carcinoma: A SEER-based study.
    Li Z; Hong Q; Guo Z; Liu X; Tan C; Feng Z; Li K
    Medicine (Baltimore); 2024 Sep; 103(38):e39480. PubMed ID: 39312373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.
    Liu J; Lyu Y; He Y; Ge J; Zou W; Liu S; Yang H; Li J; Jiang K
    J Endocrinol Invest; 2024 Jun; 47(6):1545-1557. PubMed ID: 38170396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomograms for predicting overall and cancer-specific survival in patients with papillary renal cell carcinoma: a population-based study using SEER database.
    Yan H; Wei X; Wu A; Sha Y; Li X; Qi F
    Transl Androl Urol; 2020 Jun; 9(3):1146-1158. PubMed ID: 32676398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel prognostic nomograms to assess survival in high-grade serous ovarian carcinoma after surgery and chemotherapy: a retrospective cohort study from SEER database.
    Huang W; Bao Y; Luo X; Yao L; Yuan L
    Ann Transl Med; 2022 Jul; 10(13):728. PubMed ID: 35957727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.